Araştırma Makalesi

Interleukin-1 gene variants and the risk of non-syndromic microtia

Cilt: 11 Sayı: 2 14 Mayıs 2018
Ayşe Feyda Nursal *
PDF İndir
EN TR

Interleukin-1 gene variants and the risk of non-syndromic microtia

Öz

INTRODUCTION: Microtia is a congenital anomaly, manifested by a small and disfigured auricle. Interleukin (IL) 1 is an important mediator of inflammation and cartilage destruction, This study is aimed at investigating association of IL-1A (-889) and IL-1B (-511) variants in a Turkish patient population with microtia.
METHODS: Nineteen patients diagnosed with microtia and 40 healthy controls were enrolled to the study. The IL-1A (-889) and IL-1B (-511) variants were evaluated using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. For statistical analysis, SPSS version 22.0 was used.
RESULTS: The genotype distribution of the IL-1A (-889) variant was statistically different between the cases and the control group. IL-1A -889 CC genotype was lower in microtia cases while TT genotype was more prevalent in microtia cases, respectively (p=0.008, p=0.008). High difference was also observed when the patient group and the control group were compared according to IL-1 (-889) CT+TT (p=0.003). IL-1A (-889) C allele was lower in microtia patients and T allele was higher in patients (p=0.005). The allele frequency and genotype distribution of IL-1B (-511) CT variant did not show any statistically difference between patients and controls (p>0.05).
DISCUSSION AND CONCLUSION: To our knowledge, for the first time in the literature we have demonstrated a significant association of the IL-1A (-889) functional variant with microtia in a Turkish cohort.

İngilizce Kısa Başlık: IL-1 gene variants in microtia

Anahtar Kelimeler

Microtia,interleukin-1A,interleukin-1B,variant

Kaynakça

  1. 1. Luquetti DV, Heike CL, Hing AV, Cunningham ML, Cox TC. Microtia: Epidemiology and genetics. Am J Med Genet A 2012;158A:124-39.
  2. 2. Cremers CW. Meatal atresia and hearing loss. Autosomal dominant and autosomal recessive inheritance. Int J Pediatr Otorhinolaryngol 1985;8:211-213.
  3. 3. Vishnoi M, Pandey SN, Choudhuri G, Mittal B. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population. Cancer Genet Cytogenet 2008;186:63-68.
  4. 4. Kruessel JS, Huang HY, Wen Y, Kloodt AR, Bielfeld P, Polan ML. Different pattern of interleukin-1 beta-(IL-1 beta), interleukin-1 receptor antagonist- (IL-1ra) and interleukin-1 receptor type I- (IL-1R tI) mRNA-expression in single preimplantation mouse embryos at various developmental stages. J Reprod Immunol 1997;34(2):103-120.
  5. 5. Cortial D, Gouttenoire J, Rousseau CF, et al. Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis. Osteoarthritis Cartilage 2006;14:631-640.
  6. 6. Haroon J, Hussain S, Javed Q. Heritability of IL-1A Gene Promoter Polymorphism in Patients With Coronary Artery Disease: A Trio-Family Study. Lab Med 2015;46:20-25.
  7. 7. di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992;1:450.
  8. 8. Achyut BR, Srivastava A, Bhattacharya S, Mittal B. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 2007;377:163-169.
  9. 9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
  10. 10. Maria de Freitas, N Imbronito AV, Neves AC, Nunes FD, Pustiglioni FE, Lotufo RF. Analysis of IL-1A(-889) and TNFA(-308) gene polymorphism in Brazilian patients with generalized aggressive periodontitis. Eur Cytokine Netw 2007;18:142-147.

Kaynak Göster

APA
Nursal, A. F. (2018). Interleukin-1 gene variants and the risk of non-syndromic microtia. Pamukkale Medical Journal, 11(2), 89-94. https://doi.org/10.5505/ptd.2017.94557
AMA
1.Nursal AF. Interleukin-1 gene variants and the risk of non-syndromic microtia. Pam Tıp Derg. 2018;11(2):89-94. doi:10.5505/ptd.2017.94557
Chicago
Nursal, Ayşe Feyda. 2018. “Interleukin-1 gene variants and the risk of non-syndromic microtia”. Pamukkale Medical Journal 11 (2): 89-94. https://doi.org/10.5505/ptd.2017.94557.
EndNote
Nursal AF (01 Mayıs 2018) Interleukin-1 gene variants and the risk of non-syndromic microtia. Pamukkale Medical Journal 11 2 89–94.
IEEE
[1]A. F. Nursal, “Interleukin-1 gene variants and the risk of non-syndromic microtia”, Pam Tıp Derg, c. 11, sy 2, ss. 89–94, May. 2018, doi: 10.5505/ptd.2017.94557.
ISNAD
Nursal, Ayşe Feyda. “Interleukin-1 gene variants and the risk of non-syndromic microtia”. Pamukkale Medical Journal 11/2 (01 Mayıs 2018): 89-94. https://doi.org/10.5505/ptd.2017.94557.
JAMA
1.Nursal AF. Interleukin-1 gene variants and the risk of non-syndromic microtia. Pam Tıp Derg. 2018;11:89–94.
MLA
Nursal, Ayşe Feyda. “Interleukin-1 gene variants and the risk of non-syndromic microtia”. Pamukkale Medical Journal, c. 11, sy 2, Mayıs 2018, ss. 89-94, doi:10.5505/ptd.2017.94557.
Vancouver
1.Ayşe Feyda Nursal. Interleukin-1 gene variants and the risk of non-syndromic microtia. Pam Tıp Derg. 01 Mayıs 2018;11(2):89-94. doi:10.5505/ptd.2017.94557